Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment for Infants and Children With Intermediate Risk Neuroblastoma: A Phase III Intergroup CCG/POG Study

NCT00003093 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00003093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment for Infants and Children With Intermediate Risk Neuroblastoma: A Phase III Intergroup CCG/POG Study
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
March 31, 1988
Completion date
January 31, 2011
Enrollment
573 (actual)
Sites
235

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma